B. Cheuvart

Suggest Changes
Learn More
A total of 356 patients with recurrent superficial transitional cell carcinoma of the bladder was entered in a randomized clinical trial to compare intravesical thiotepa, doxorubicin and cisplatin(More)
  • 1